Attention to body mass index by child psychiatry providers when prescribing second-generation antipsychotic medication to children: a survey study using a clinical vignette

作者：Fromson John A^*; Sutton Skinner Kelly M; Gorrindo Tristan; Baer Lee; Romeo Sarah A; Rieu Werden Meghan L; Birnbaum Robert J

来源：Early Intervention in Psychiatry, 2012, 6(2): 195-200.

DOI：10.1111/j.1751-7893.2011.00332.x

• adverse effect
• antipsychotic agent
• body mass index
• child psychiatry
• guideline adherence

Aim: We sought to determine whether weight and body mass index measurement were taken into consideration when prescribing second-generation antipsychotic (SGA) medication to a child. Methods: Two hundred clinicians were surveyed using a hypothetical clinical case vignette at a child psychopharmacology, postgraduate medical education course. The vignette described an overweight 10-year-old boy who was about to be prescribed an SGA medication to control psychotic symptoms. The reference to the patient's being ` overweight' was purposefully included to determine if providers would assess the patient's risk of morbidity from the metabolic side effects of the SGAs at the time of prescribing. Results: Only 7.0% of prescribers listed either ` body mass index' or a combination of ` height' and ` weight' as part of their next treatment steps for an overweight child before prescribing an SGA. Conclusions: These results suggest the need for education as to the importance of body mass index monitoring when prescribing secondgeneration antipsychotic medications to children.

• 出版日期2012-5